A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Epistemonikos ID: 2d047b9e81ba294d92a7c5da7462e6f9e4442b8b
First added on: Apr 17, 2026